Literature DB >> 21118757

Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: application for point-of-care diagnostics.

David M Pearce1, Daniel P Shenton, Jeffrey Holden, Charlotte A Gaydos.   

Abstract

Atlas Genetics has developed a point-of-care device for Chlamydia trachomatis utilizing a novel electrochemical detection principle. The assay has a time-to-result of less than 25 min. An independent preclinical validation study using 306 pretyped clinical samples determined a clinical sensitivity of 98.1% and specificity of 98.0%.

Entities:  

Mesh：

Year:  2010        PMID： 21118757      PMCID： PMC3187616          DOI： 10.1109/TBME.2010.2095851

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN： 0018-9294            Impact factor:   4.538


  4 in total

1.  Evaluation of rapid diagnostic tests: chlamydia and gonorrhoea.

Authors:  Alan Herring; Ron Ballard; David Mabey; Rosanna W Peeling
Journal:  Nat Rev Microbiol       Date:  2006-12       Impact factor: 60.633

2.  Screening for chlamydia--a key to the prevention of pelvic inflammatory disease.

Authors:  S D Hillis; J N Wasserheit
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

3.  An electrochemical study of enzymatic oligonucleotide digestion.

Authors:  Stephen C Hillier; Christopher G Frost; A Toby A Jenkins; Helen T Braven; Russell W Keay; Stephen E Flower; John M Clarkson
Journal:  Bioelectrochemistry       Date:  2004-06       Impact factor: 5.373

4.  Rapid electrochemical identification of pathogenic Candida species.

Authors:  Alastair Muir; A Toby A Jenkins; Gordon Forrest; John Clarkson; Alan Wheals
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472
  4 in total
  14 in total

Review 1.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

Review 2.  Existing and Emerging Technologies for Point-of-Care Testing.

Authors:  Andrew St John; Christopher P Price
Journal:  Clin Biochem Rev       Date:  2014-08

Review 3.  Point of care diagnostics for sexually transmitted infections: perspectives and advances.

Authors:  Charlotte Gaydos; Justin Hardick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-02-03       Impact factor: 5.091

4.  A new rapid molecular point-of-care assay for Trichomonas vaginalis: preliminary performance data.

Authors:  David M Pearce; David N Styles; Justin P Hardick; Charlotte A Gaydos
Journal:  Sex Transm Infect       Date:  2013-04-20       Impact factor: 3.519

5.  Performance of the Atlas Genetics Rapid Test for Chlamydia trachomatis and Women's Attitudes Toward Point-Of-Care Testing.

Authors:  Lea E Widdice; Yu-Hsiang Hsieh; Barbara Silver; Mathilda Barnes; Perry Barnes; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2018-11       Impact factor: 2.830

Review 6.  The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.

Authors:  Daniel H F Rubin; Jonathan D C Ross; Yonatan H Grad
Journal:  Transl Res       Date:  2020-02-29       Impact factor: 7.012

7.  STI management and control in North America IUSTI region.

Authors:  Charlotte A Gaydos
Journal:  Sex Transm Infect       Date:  2011-12       Impact factor: 3.519

8.  Combination of ferrocene decorated gold nanoparticles and engineered primers for the direct reagentless determination of isothermally amplified DNA.

Authors:  Sallam Al-Madhagi; Ciara K O'Sullivan; Mamas I Prodromidis; Ioanis Katakis
Journal:  Mikrochim Acta       Date:  2021-03-09       Impact factor: 5.833

9.  Performance of point-of-care tests for the detection of chlamydia trachomatis infections: A systematic review and meta-analysis.

Authors:  Ying Zhou; Ting-Ting Jiang; Jing Li; Yue-Ping Yin; Xiang-Sheng Chen
Journal:  EClinicalMedicine       Date:  2021-06-18

Review 10.  A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men.

Authors:  Barbara Van Der Pol; Charlotte A Gaydos
Journal:  Expert Rev Mol Diagn       Date:  2021-07-12       Impact factor: 5.670
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.